[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627897":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":28,"responsibleParty":45,"collaborators":7,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Wren Laboratories LLC","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","PROSTEST","BLOOD SAMPLE FOR PROSTEST MEASUREMENT",[14],{"name":15,"affiliation":16,"role":17},"Abdel Halim, PharmD, PhD","Wren Laboratories","STUDY_CHAIR",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Mark Kidd, PhD","CONTACT","2038241128","mkidd@wrenlaboratories.com",{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},"Tracy Auster, BS","2032083464","tauster@wrenlaboratories.com",[29],{"facility":16,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Branford","Connecticut","06405","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-72.8151,41.27954,{"lat":40,"lon":39},[43,44],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},{"type":46,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100627897","a-prospective-clinical-trial-evaluating-prostest-a-blood-based-molecular-assay-for-risk-stratification-and-biopsy-decision-support-in-men-with-suspected-prostate-cancer-100627897",false,"NCT07454603","A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng\u002Fml Using Biopsy as the Sole Ground Truth","PROSTest_STRAT","Inclusion Criteria:\n\n* elevated PSA and\u002For abnormal digital rectal examination\n\nExclusion Criteria:\n\n* Previous Prostate cancer diagnosis","MALE","45 Years","80 Years",{"count":58,"type":59},1500,"ESTIMATED","OBSERVATIONAL","This prospective observational study will enroll men referred for prostate biopsy due to elevated PSA and\u002For abnormal digital rectal examination, with or without pre-biopsy MRI. Peripheral blood will be collected prior to biopsy for PROSTest analysis. Biopsy histopathology will serve as the reference standard. PROSTest results will be analyzed blinded to pathology.",[63,64,65],"Prostate Cancer","Urology","Prostate Cancer (Diagnosis)",[67,68,69],"BIOPSY","MRI","PROSTATE CANCER","2026-08-19",{"date":72,"type":73},"2026-08-21","ACTUAL",{"date":75,"type":73},"2026-04-15",{"date":77,"type":59},"2027-06-01",{"name":5,"class":6},1]